ABCELLERA BIOLOGICS INC's ticker is ABCL and the CUSIP is 00288U106. A total of 131 filers reported holding ABCELLERA BIOLOGICS INC in Q1 2022. The put-call ratio across all filers is 0.31 and the average weighting 1.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $403 | -29.4% | 87,000 | 0.0% | 0.00% | 0.0% |
| Q2 2023 | $571 | -11.1% | 87,000 | 0.0% | 0.00% | -50.0% |
| Q1 2023 | $642 | -26.0% | 87,000 | 0.0% | 0.00% | 0.0% |
| Q4 2022 | $867 | -99.9% | 87,000 | 0.0% | 0.00% | -33.3% |
| Q3 2022 | $850,000 | -1.7% | 87,000 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $865,000 | -52.6% | 87,000 | -53.5% | 0.00% | -25.0% |
| Q1 2022 | $1,823,000 | -31.3% | 187,000 | -4.1% | 0.00% | -33.3% |
| Q4 2021 | $2,654,000 | – | 195,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Founders Fund VII Management, LLC | 3,773,530 | $38,225,859 | 94.47% |
| Founders Fund Growth Management, LLC | 407,017 | $4,123,082 | 20.66% |
| Gruss & Co., LLC | 255,400 | $2,587,202 | 15.98% |
| Belmont Capital, LLC | 510,000 | $5,166 | 5.52% |
| HARVARD MANAGEMENT CO INC | 4,105,095 | $41,584,612 | 5.16% |
| Intellectus Partners, LLC | 868,583 | $8,798,743 | 3.06% |
| GUARDIAN CAPITAL ADVISORS LP | 1,786,414 | $18,221,423 | 2.07% |
| BRANDYWINE MANAGERS, LLC | 56,976 | $577,167 | 2.02% |
| Prosight Management, LP | 322,754 | $3,269,498 | 1.78% |
| Casdin Capital, LLC | 2,270,000 | $22,995,100 | 1.78% |